Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.
Giulio ViceconteAntonio Riccardo BuonomoAlessia D'AgostinoMaria FoggiaAntonio Di FuscoPinchera BiagioRiccardo ScottoCarmine IacovazzoLuca FanascaGaetana MessinaFrancesco CacciatorePaola SalvatoreGentile Ivannull On Behalf Of The Federico Ii Covid TeamPublished in: Journal of fungi (Basel, Switzerland) (2023)
PJP develops in COVID-19 patients regardless of immunosuppressive conditions and the severity of disease, and it is correlated to the corticosteroid dose received.
Keyphrases
- sars cov
- end stage renal disease
- coronavirus disease
- ejection fraction
- newly diagnosed
- antiretroviral therapy
- hiv infected
- hiv positive
- hepatitis c virus
- hiv testing
- hiv aids
- patient reported outcomes
- intensive care unit
- men who have sex with men
- respiratory syndrome coronavirus
- acute respiratory distress syndrome